Efficacy and safety of external therapy of TCM for diabetic peripheral vascular disease: A protocol for systematic review and meta-analysis

Abstract

Background: In modern society, the incidence of diabetes is increasing yearly, and poor glycemic control can accelerate the progression and severity of diabetic peripheral vascular disease. External treatment with traditional Chinese medicine (TCM) has been widely used in the treatment of diabetes, but there is no systematic review on the external treatment of TCM for diabetic peripheral vascular disease; therefore, this study aimed to conduct a meta-analysis on the clinical efficacy and safety of external treatment of TCM in the treatment of diabetic peripheral vascular diseases. Methods: We searched The Cochrane Library, PubMed, Web of Science, EMBASE, China Science and Technology Journal, China National Knowledge Infrastructure, Wanfang, Chinese Biomedical Literature Database, and other sources from their respective inception dates to October 20, 2022, to identify potentially eligible studies. We will use Review Manager 5.4 software provided by the Cochrane Collaborative Network for statistical analysis. We then assessed the quality and risk of the included studies and observed their outcome measures. Results: Changes in the bilateral femoral artery, popliteal artery, dorsal artery diameter, blood flow, ankle/brachial index, and dorsal foot temperature: An overall reduction in symptoms (a reduction in diabetes-related symptoms that occur only during the intervention or as a result of the intervention, including peripheral vascular disease). Conclusion: The objective of this meta-analysis was to investigate the influence of external treatment of traditional Chinese medicine on diabetic peripheral vascular disease and to provide more methods for the clinical prevention and treatment of diabetic peripheral vascular disease.

Plasma activated Ezhangfeng Cuji as innovative antifungal agent and its inactivation mechanism

“…In one study, immunodeficient nude mice were given PAW orally, and following treatment, there were no appreciable alterations in their blood biochemical parameters or tissue structure, proving that PAW had no substantial safety issues (Xu et al 2018a ). In recent years, external therapy using TCM has demonstrated positive results in treating diabetic peripheral vascular disease, psoriasis and other skin diseases without adverse effects, confirming the cellular safety of aqueous solutions of Chinese herbs (Ding et al 2022 ; Zhang et al 2022 ). Nowadays, despite the fact that many individuals investigate plasma-activated liquids, the majority of studies tend to focus on their sterilisation or degrading processes rather than their safety.…”

Exploring the potential mechanism of Simiao Yongan decoction in the treatment of diabetic peripheral vascular disease based on network pharmacology and molecular docking technology

“…Diabetic Peripheral Vascular Disease (DPVD) is a common complication of diabetes, characterized as a chronic ischemic disease caused by atherosclerosis in the peripheral arteries over the course of long-term pathological changes. [ 1 ] Diabetes is a global public health challenge, with an estimated 51% increase in the number of diabetic patients worldwide by 2045, reaching 700 million. Among these, approximately 9.5% of diabetic patients over the age of 40 suffer from peripheral vascular disease, and the incidence of peripheral vascular disease in patients with diabetes for 5 years or more is as high as 90%.…”